The Bard PowerPort and AngioDynamics SmartPort are totally implantable venous access devices (TIVADs) used to deliver chemotherapy and other medications. After thousands of catheter-fracture and infection reports, the federal MDL — In re: Bard Implanted Port Catheter Products Liability Litigation, MDL No. 3081 — was consolidated in the District of Arizona. Our firm represents qualifying Bard PowerPort and SmartPort claimants.

Who Qualifies

All of the following must be true:

• You had a totally implantable venous access port implanted to deliver chemotherapy or other medications. (Ports implanted for dialysis access do not qualify.)
• The implant occurred after 2008. (Earlier implants may qualify if medical records are available.)
• You suffered a hospitalization caused by one or more of the following:
  • Organ perforation
  • Blood clots
  • Embolism
  • Infection lasting more than 30 days
  • Other listed device-related complications

What to Send Us

• Implant card or device serial number, if available.
• Brand of the device — Bard PowerPort or AngioDynamics SmartPort.
• Hospital records showing the complication and treatment.
• Operative report from the implant procedure if you have it.

About the Bard PowerPort MDL

The federal MDL is consolidated before a federal judge in the District of Arizona. Discovery and bellwether-trial preparation are active. Litigation status changes — read our plain-language MDL guide for an overview of how these cases move through the federal courts, or call our office for the most current information about your situation.

Start Your Bard PowerPort Case

If you fit the criteria above, please contact our office for a free, confidential evaluation. There is no cost to discuss your potential claim, and there is no fee unless we recover compensation for you.